Physician

Ophthalmology

Dr. Theresa A. Larson, MD


Theresa Larson works in the field of Ophthalmology. She went to medical school at Vanderbilt University School of Medicine. She received awards:"Fellow (FAAO)". Theresa Larson is a published MD. She has 4 papers published. The most current publication "The Variable Efficacy of Intravitreal Bevacizumab and Triamcinolone Acetonide for Cystoid Macular Edema Due to Radiation Retinopathy."



Publications


Schools


Procedures Preformed


Doctors Specialties


Accepted Insurances


Awards


Education


Drug Facts


NPI NUMBER   1881606739
NPPES Provider LastName   LARSON
NPPES Provider FirstName   THERESA
NPPES Provider ZIPCode   731045014
NPPES Provider State   OK
Specialty Description   Ophthalmology
Total Claim Count   919.0
Distinct Opioid Count   0.0
Opioid Claim Count   0.0
Percent Opioid Claims   0.0

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1881606739
Last Name Of The Provider LARSON
First Name Of The Provider THERESA
View All

Similar Doctors


Dr. David E. Korber, MD
This Doctor is OpenDoctor Recommended.
Dr. Anil D. Patel, MD
This Doctor is OpenDoctor Recommended.
Dr. Darrell J. Pickard, MD
This Doctor is OpenDoctor Recommended.
Dr. Alex W. Cohen, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Ronald M. Kingsley, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Deena A. Sylvester, MD
This Doctor is OpenDoctor Recommended.
Dr. Sterling Baker, MD
This Doctor is OpenDoctor Recommended.
Dr. Ralph B. Hester III, MD
This Doctor is OpenDoctor Recommended.
Dr. Annie Moreau, MD
This Doctor is OpenDoctor Recommended.
Dr. John P. Keenan, MD
This Doctor is OpenDoctor Recommended.
Dr. Sumit K. Nanda, MD
This Doctor is OpenDoctor Recommended.
Dr. Rhea L. Siatkowski, MD
This Doctor is OpenDoctor Recommended.
Dr. Nabil E. Srouji, MD
This Doctor is OpenDoctor Recommended.
Dr. Derek P. Bitner, MD
This Doctor is OpenDoctor Recommended.


Doctor Directory | TOS | twitter | FB | Angel | blog